By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Tuesday, 10.24.2017, Baltimore, MD, Insilico Medicine, a leader in the field of artificial intelligence, is pleased to announce its founder and CEO, Dr. Alex Zhavoronkov, will present at The World Congress on Targeting Metabesity in London, UK on Tuesday, October 31 in Session VIII: Are New Business Models Needed?
Dr. Zhavoronkov's presentation will focus on recent advances in artificial intelligence specifically in deep learning allow for novel ways to identify the disease targets, generate novel molecular structures for these targets, track the effects of the various interventions and improve behavior (see also Disease Attributes - Chronic Disease).
Metabesity refers to the major public health challenges--cardiovascular disease, cancer, dementia, diabetes and the aging process itself--all of which share metabolic roots. These metabolically connected disorders can be targeted to prevent--not just manage them. Metabesity2017 aims at these stretch goals by engaging world-renowned scientific experts, executives, policy makers, and other stakeholders across the fields of metabolic-rooted disorders. The distinctive objective of Metabesity2017 is to devise cross-cutting strategies to leverage impact of this science and technology.
Dr. Zhavoronkov, PhD, founder and CEO of Insilico Medicine, Inc said, "Targeting metabesity is the low-hanging fruit for extending human longevity and improving the quality of life. Recent advances in artificial intelligence specifically in deep learning allow for novel ways to identify the disease targets, generate novel molecular structures for these targets, track the effects of the various interventions and improve behavior. We are very happy to present our work at this unique and most important conference, Metabesity2017, which will catalyze interdisciplinary progress."
Dr. Alexander Fleming, Founder and Chairman of Kinexum, commented: "We are delighted to have Alex participate in this inaugural congress, which annually will help to accelerate collaboration, creativity, and productivity in the fields of chronic disease prevention and healthy lifespan extension. He has not only contributed immensely to scientific and technical progress, but he is the personal embodiment of what the Metabesity movement aims to be--connecting and invigorating disparate experts, institutions, and resources to pursue daunting goals.
Keywords for this news article include: Machine Learning, Risk and Prevention, Emerging Technologies, InSilico Medicine Inc., Artificial Intelligence, Disease Attributes - Chronic Disease.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC